Irit Avni‐Biron

1.4k total citations
33 papers, 309 citations indexed

About

Irit Avni‐Biron is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Irit Avni‐Biron has authored 33 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 17 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Irit Avni‐Biron's work include Inflammatory Bowel Disease (21 papers), Microscopic Colitis (12 papers) and Eosinophilic Esophagitis (9 papers). Irit Avni‐Biron is often cited by papers focused on Inflammatory Bowel Disease (21 papers), Microscopic Colitis (12 papers) and Eosinophilic Esophagitis (9 papers). Irit Avni‐Biron collaborates with scholars based in Israel, United States and Sweden. Irit Avni‐Biron's co-authors include Ofer Ben‐Bassat, Lev Lichtenstein, Henit Yanai, Iris Dotan, Ariella Bar‐Gil Shitrit, Uri Kopylov, Yulia Ron, Eran Zittan, Nitsan Maharshak and Benjamin Koslowsky and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Irit Avni‐Biron

29 papers receiving 302 citations

Peers

Countries citing papers authored by Irit Avni‐Biron

Since Specialization

Citations

This map shows the geographic impact of Irit Avni‐Biron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irit Avni‐Biron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irit Avni‐Biron more than expected).

Fields of papers citing papers by Irit Avni‐Biron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irit Avni‐Biron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irit Avni‐Biron. The network helps show where Irit Avni‐Biron may publish in the future.

Co-authorship network of co-authors of Irit Avni‐Biron

This figure shows the co-authorship network connecting the top 25 collaborators of Irit Avni‐Biron. A scholar is included among the top collaborators of Irit Avni‐Biron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irit Avni‐Biron. Irit Avni‐Biron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical stages of Crohn’s disease defined by faecal calprotectin in asymptomatic first-degree relatives: screening framework for prevention trials 2025 ·Gut ·Dan Turner, (unknown), Gili Focht, Williams Turpin, Oren Ledder, Anne M. Griffiths, Hien Q. Huynh, (unknown), (unknown), Wael El‐Matary, Anthony Otley, Irit Avni‐Biron, Kevan Jacobson, Remo Panaccione, Joana Torres, Sun-Ho Lee, Kenneth Croitoru	0
2	The Role of Small-Bowel Capsule Endoscopy in the Diagnostic Algorithm of Complicated Perianal Disease 2024 ·Diagnostics ·Irit Avni‐Biron, Ervin Tóth, Jacob E. Ollech, Artúr Németh, (unknown), (unknown), (unknown), Uri Kopylov, Iris Dotan, Henit Yanai	1
3	Factors Associated With Biologic Therapy After Ileal Pouch–Anal Anastomosis in Patients With Ulcerative Colitis 2024 ·Inflammatory Bowel Diseases ·(unknown), Lihi Godny, (unknown), (unknown), Ian White, Nir Wasserberg, Keren M. Rabinowitz, Irit Avni‐Biron, (unknown), Yifat Snir, (unknown), Henit Yanai, Iris Dotan, Jacob E. Ollech	1
4	Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis 2024 ·Digestive and Liver Disease ·Tom Konikoff, (unknown), Henit Yanai, (unknown), Uri Kopylov, Ahmad Albshesh, Roni Weisshof, (unknown), (unknown), Irit Avni‐Biron, Yifat Snir, (unknown), (unknown), Leor Perl, Iris Dotan, Jacob E. Ollech	0
5	P244 The first step to IBD prevention exploring rate of pre-clinical inflammation in subset of asymptomatic subjects at risk of IBD: screening stage of the PIONIR trial 2024 ·Journal of Crohn s and Colitis ·(unknown), Williams Turpin, (unknown), Oren Ledder, (unknown), Anne M. Griffiths, (unknown), Wael El‐Matary, Anthony Otley, Irit Avni‐Biron, Kevan Jacobson, Remo Panaccione, Alain Bitton, Ken Croitoru, Dan Turner	1
6	P331 Photoplethysmography waveform analysis detects inflammatory status in patients with inflammatory bowel disease 2024 ·Journal of Crohn s and Colitis ·Yehuda Chowers, (unknown), (unknown), Jacob E. Ollech, Noam Peleg, Yifat Snir, Irit Avni‐Biron, (unknown), Henit Yanai, Iris Dotan	0
7	A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes 2023 ·Crohn s & Colitis 360 ·Henit Yanai, (unknown), Idan Goren, (unknown), Jacob E. Ollech, Yifat Snir, (unknown), (unknown), Tamar Pfeffer‐Gik, Lihi Godny, (unknown), (unknown), Maor H. Pauker, Keren M. Rabinowitz, Irit Avni‐Biron, Iris Dotan	2
8	Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center 2023 ·Journal of Clinical Medicine ·Irit Avni‐Biron, (unknown), Jacob E. Ollech, (unknown), (unknown), (unknown), Maor H. Pauker, (unknown), Iris Dotan, Eran Hadar, Henit Yanai	3
9	Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data 2023 ·Journal of Clinical Medicine ·Tom Konikoff, Henit Yanai, (unknown), Irit Avni‐Biron, Yifat Snir, (unknown), (unknown), Iris Dotan, Jacob E. Ollech	2
10	SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy 2022 ·Vaccines ·Irit Avni‐Biron, (unknown), (unknown), Eran Hadar, Michal Neeman, Romina Plitman Mayo, Hen Y. Sela, Simcha Yagel, (unknown), Ami Ben Yaʼacov, (unknown), Jacob E. Ollech, (unknown), Keren M. Rabinowitz, Maor H. Pauker, Henit Yanai, Sophy Goren, Dani Cohen, Iris Dotan, Ariella Bar‐Gil Shitrit	1
11	Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study 2022 ·Alimentary Pharmacology & Therapeutics ·Irit Avni‐Biron, (unknown), Eran Zittan, (unknown), (unknown), (unknown), (unknown), Uri Kopylov, Yulia Ron, Eran Hadar, (unknown), (unknown), Jacob E. Ollech, Ayelet Arazi, Rivka Farkash, Maor H. Pauker, Henit Yanai, Iris Dotan, Ariella Bar‐Gil Shitrit	24
12	Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience 2022 ·Digestive Diseases ·Noam Peleg, Henit Yanai, Rachel Gingold‐Belfer, Iris Dotan, Irit Avni‐Biron	1
13	Immune function in newborns with in-utero exposure to anti-TNFα therapy 2022 ·Frontiers in Pediatrics ·Batia Weiss, Shomron Ben‐Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni‐Biron, Anat Yerushalmy‐Feler, Amit Assa, Raz Somech, Ariella Bar‐Gil Shitrit	13
14	Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial 2022 ·The American Journal of Gastroenterology ·Jacob E. Ollech, Henit Yanai, Irit Avni‐Biron, Yifat Snir, (unknown), (unknown), Lihi Godny, Nir Wasserberg, Ian R. White, Iris Dotan	4
15	Machine learning for selecting patients with Crohn's disease for abdominopelvic computed tomography in the emergency department 2021 ·Digestive and Liver Disease ·Tom Konikoff, Idan Goren, (unknown), (unknown), Irit Avni‐Biron, Henit Yanai, Iris Dotan, Jacob E. Ollech	6
16	Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes 2020 ·Clinical Gastroenterology and Hepatology ·Jacob E. Ollech, Irit Avni‐Biron, Laura Glick, (unknown), Sushila Dalal, Dejan Micić, Joel Pekow, Henit Yanai, (unknown), Iris Dotan, David T. Rubin, Atsushi Sakuraba	11
17	Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience 2018 ·Digestive and Liver Disease ·Uri Kopylov, Irit Avni‐Biron, Yulia Ron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Doron Schwartz, Eran Zittan, (unknown), Henit Yanai, Nitsan Maharshak, (unknown), Timna Naftali, Rami Eliakim, Yehuda Chowers, Shomron Ben‐Horin, Iris Dotan	21
18	Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience 2017 ·Inflammatory Bowel Diseases ·Uri Kopylov, Yulia Ron, Irit Avni‐Biron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Henit Yanai, Nitsan Maharshak, Ofer Ben‐Bassat, Lev Lichtenstein, Ariella Bar‐Gil Shitrit, Eran Israeli, Doron Schwartz, Eran Zittan, Rami Eliakim, Yehuda Chowers, Shomron Ben‐Horin, Iris Dotan	82
19	The current place of probiotics and prebiotics in the treatment of pouchitis 2016 ·Best Practice & Research Clinical Gastroenterology ·Lev Lichtenstein, Irit Avni‐Biron, Ofer Ben‐Bassat	7
20	Probiotics and prebiotics in Crohn's disease therapies 2016 ·Best Practice & Research Clinical Gastroenterology ·Lev Lichtenstein, Irit Avni‐Biron, Ofer Ben‐Bassat	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact